| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/11/2009 | CN100460019C Microparticles comprising carbohydrate beads covalently linked with allergen |
| 02/11/2009 | CN100460018C Polybutylcyanoacrylate nano-granule with resolubity, application and use thereof |
| 02/11/2009 | CN100460017C Total arasaponin precursor liposome and prepn process thereof |
| 02/11/2009 | CN100460016C Meso-porous nanometer particle of calcium phosphate, preparation method and application thereof |
| 02/11/2009 | CN100459978C Rosiglitazone slow-release tablet and preparation method thereof |
| 02/11/2009 | CN100459976C Compound paclitaxel preparation containing phospholipid dispersant and preparation method thereof |
| 02/10/2009 | US7488801 Interferon-alpha polypeptides and conjugates |
| 02/10/2009 | US7488598 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/10/2009 | US7488590 Fusion of Fc domains with biologically active peptides; selecting peptide that modulates the activity of AGP-3, preparing a gene construct; expressing the pharmacologically active compound in which an Fc domain is covalently linked to peptide |
| 02/10/2009 | US7488589 Interferon-alpha polypeptides and conjugates |
| 02/10/2009 | US7488533 Highly oil absorbing amorphous silica particles |
| 02/10/2009 | US7488498 Controlled release nateglimide formulation; reducing blood glucose concentration |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | US7488491 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 02/10/2009 | US7488473 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
| 02/10/2009 | CA2562418C Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof |
| 02/10/2009 | CA2413578C Use of dicalcium phosphate anhydride powder |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/10/2009 | CA2385732C Bicyclic compounds composition and method for stabilizing the same |
| 02/10/2009 | CA2358448C Dispersible concentrate for the delivery of cyclosporin |
| 02/10/2009 | CA2354057C Sustained release tablet containing hydrocolloid and cellulose ether |
| 02/10/2009 | CA2346988C Pharmaceutical formulation comprising omeprazole |
| 02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/10/2009 | CA2292226C Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use |
| 02/10/2009 | CA2280628C Soft chewable tablets |
| 02/05/2009 | WO2009018356A1 Immune system modulator formulation |
| 02/05/2009 | WO2009018175A2 Cyclic azapeptides as integrin markers |
| 02/05/2009 | WO2009017259A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 02/05/2009 | WO2009017250A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 02/05/2009 | WO2009016663A1 Amphiphilic dextrin conjugates and their use in pharmaceutical formulations as complexing agents for hydrophobic drugs to improve the aqueous solubility and consequently the therapeutic efficacy of the complexed drugs |
| 02/05/2009 | WO2009016333A1 Osteogenic compounds |
| 02/05/2009 | WO2009016275A2 Method for enzyme cleavage of polysaccharides derived from algae |
| 02/05/2009 | WO2009016258A1 Aqueous polymer dispersion based on n,n-diethylaminoethyl methacrylate, its preparation and use |
| 02/05/2009 | WO2009016181A2 Optical imaging agents |
| 02/05/2009 | WO2009016180A2 Peptide imaging agents |
| 02/05/2009 | WO2009016131A1 Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 02/05/2009 | WO2009016069A2 Stable liquid pharmaceutical composition based on trazodone |
| 02/05/2009 | WO2009016031A1 Oxidized avidin with high residency time in the treated tissues |
| 02/05/2009 | WO2009015475A1 Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid |
| 02/05/2009 | WO2009015456A1 Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray |
| 02/05/2009 | WO2008153753A3 Compositions and particles containing cellulosic fibers and stabilized- and/or activated- urease inhibitors, as well as methods of making and using the same |
| 02/05/2009 | WO2008149320A3 Slow release pharmaceutical composition made of microparticles |
| 02/05/2009 | WO2008149192A3 Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
| 02/05/2009 | WO2008135852A3 Pharmaceutical compositions comprising nanoparticles and casein |
| 02/05/2009 | WO2008134557A3 Solid dosage forms |
| 02/05/2009 | WO2008100482A3 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 02/05/2009 | US20090036851 Personal-care articles having self-assembling peptides |
| 02/05/2009 | US20090036554 Ophthalmic compositions comprising a terpene compound |
| 02/05/2009 | US20090036553 Dendritic encapsulation of active agents |
| 02/05/2009 | US20090036552 Noninvasive Drug Delivery System To Tissue of Posterior Segment of Eye Using Solid Composition |
| 02/05/2009 | US20090036551 Copolymers based on n-vinyl lactams and olefins as their use as solubilizers for slightly water-soluble compounds |
| 02/05/2009 | US20090036550 Copolymers Based on Polyalkylene Oxide-Modified N-Vinyl Lactam Copolymers |
| 02/05/2009 | US20090036549 Substance-encapsulated carbon nanohorn complex and producing method thereof |
| 02/05/2009 | US20090036548 Mascara and liquid eyeliner enhancer |
| 02/05/2009 | US20090036531 Method for treatment of onychomycosis |
| 02/05/2009 | US20090036517 Anti-angiogenic compositions and methods of use |
| 02/05/2009 | US20090036491 Transdermal pharmaceutical delivery compositions |
| 02/05/2009 | US20090036389 Polymeric Micelle Formulations of Hydrophobic Compounds and Methods |
| 02/05/2009 | US20090036363 Peptides as cell penetrating carriers |
| 02/05/2009 | US20090036354 Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| 02/05/2009 | US20090035853 Tsg101-gag interaction and use thereof |
| 02/05/2009 | US20090035389 Targeted protein cages |
| 02/05/2009 | US20090035384 Process for producing coated urea-formaldehyde polymers |
| 02/05/2009 | US20090035381 Electrospraying method for fabrication of particles and coatings and treatment methods thereof |
| 02/05/2009 | US20090035379 Fenofibrate compositions |
| 02/05/2009 | US20090035372 method for manufacturing a pharmaceutical composition for controlled release of an active substance |
| 02/05/2009 | US20090035358 Phosphatidyl oligoglycerols |
| 02/05/2009 | US20090035333 Cosmetic skin preparation |
| 02/05/2009 | US20090035326 Compositions with antigens adsorbed to calcium phosphate |
| 02/05/2009 | US20090035308 Methods for using and identifying modulators of Delta-like 4 |
| 02/05/2009 | US20090035265 Compositions and Methods for Targeted Delivery of Factors |
| 02/05/2009 | US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 02/05/2009 | US20090035253 Poly(lactide-Co-glycolide) based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/05/2009 | US20090035233 Conversion of liquid formulations to a powder |
| 02/05/2009 | CA2697779A1 Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid |
| 02/05/2009 | CA2695178A1 Methods for producing aripiprazole suspension and freeze-dried formulation |
| 02/05/2009 | CA2694610A1 Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method |
| 02/05/2009 | CA2694600A1 Complexes between an amphiphilic polymer and an osteogenic protein of the bmps family |
| 02/05/2009 | CA2694391A1 Oxidized avidin with high residency time in the treated tissues |
| 02/05/2009 | CA2694139A1 New compositions, methods and uses |
| 02/05/2009 | CA2694102A1 Optical imaging agents |
| 02/05/2009 | CA2693364A1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol |
| 02/05/2009 | CA2692975A1 Stable liquid pharmaceutical composition based on trazodone |
| 02/04/2009 | EP2020438A1 Treatment of pompe's disease |
| 02/04/2009 | EP2020256A1 Sulfur containing dermatological compositions |
| 02/04/2009 | EP2020243A1 Topically applicable pharmaceutical preparation |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2020229A1 Multiparticulate modified release composition |
| 02/04/2009 | EP2019952A2 Stabilized formulation of triamcinolone acetonide |
| 02/04/2009 | EP2019693A2 High molecular weight chelation structure |
| 02/04/2009 | EP2019691A2 Polymers for functional particles |
| 02/04/2009 | EP2019690A2 Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu's reaction |
| 02/04/2009 | EP2019689A2 Pharmaceutical composition and vaccine against staphylococcal infections |
| 02/04/2009 | EP2019681A2 Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
| 02/04/2009 | EP2019666A2 Pharmaceutical preparations for transdermal use |
| 02/04/2009 | EP2019664A1 Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same |
| 02/04/2009 | EP2019647A2 Novel hydrophilic polymers as medical lubricants and gels |
| 02/04/2009 | EP2019645A2 Delivery of ophthalmologic agents to the exterior or interior of the eye |
| 02/04/2009 | EP1534237B1 Orally disintegrating tablets and process for obtaining them. |